Management of intracranial haemorrhage in a newborn with inherited factor VII deficiency with the use of rFVIIa aliquots.
作者信息
Désage Stéphanie, Chamouard Valérie, Meunier Sandrine, Enjolras Nathalie, Sobas Frédéric, Négrier Claude, Le Quellec Sandra
机构信息
Unité d'hémostase clinique, Hôpital cardiologique Louis Pradel, Hospices Civils de Lyon, Lyon, France.
EA 4609 Hémostase et cancer, Université Claude Bernard Lyon 1, Lyon, France.
出版信息
Haemophilia. 2021 Jul;27(4):e487-e490. doi: 10.1111/hae.14199. Epub 2020 Nov 20.
PMID:33215792
Abstract
摘要
相似文献
1
Management of intracranial haemorrhage in a newborn with inherited factor VII deficiency with the use of rFVIIa aliquots.
Haemophilia. 2021 Jul;27(4):e487-e490. doi: 10.1111/hae.14199. Epub 2020 Nov 20.
2
Successful prophylaxis against intracranial hemorrhage using weekly administration of activated recombinant factor VII in a newborn with severe factor VII deficiency.
J Thromb Haemost. 2007 Feb;5(2):433-4. doi: 10.1111/j.1538-7836.2007.02318.x. Epub 2006 Nov 16.
3
Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII.
Turk J Pediatr. 2018;60(5):562-565. doi: 10.24953/turkjped.2018.05.014.
4
Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath.
Semin Hematol. 2008 Apr;45(2 Suppl 1):S74. doi: 10.1053/j.seminhematol.2008.03.010.
5
Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency.
Haemophilia. 2000 Jan;6(1):50-4. doi: 10.1046/j.1365-2516.2000.00345.x.
6
Recombinant activated factor VII for a patient with factor VII deficiency undergoing urgent intracerebral haematoma evacuation with underlying cavernous angioma.
Br J Anaesth. 2009 Dec;103(6):858-60. doi: 10.1093/bja/aep293. Epub 2009 Oct 20.
7
Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review.
Eur J Obstet Gynecol Reprod Biol. 2019 Apr;235:77-80. doi: 10.1016/j.ejogrb.2019.02.017. Epub 2019 Feb 22.
8
Long-term follow-up of prophylaxis with recombinant activated factor VII in patients with congenital factor VII deficiency.
Haemophilia. 2011 Jul;17(4):713-5. doi: 10.1111/j.1365-2516.2010.02471.x. Epub 2011 Feb 7.
9
[Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report].
Ann Biol Clin (Paris). 2011 Nov-Dec;69(6):713-9. doi: 10.1684/abc.2011.0623.
10
Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Hematology. 2007 Feb;12(1):55-62. doi: 10.1080/10245330601111573.
Zotero 插件